Achyut Healthcare Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 543499
₹6.03
▼ -0.21 (-3.37%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
41/100
Moderate
Valuation
37/100
Fairly Valued
Momentum
42/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹146 Cr
PE (TTM)
Data unavailable.
Price to Book
4.2
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
67.0
Free Cash Flow
₹-7 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
4.59
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
Data unavailable.
Net Margin
4.57%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
6.43%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 4 met
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 1 met
  • Yes 1-year return beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.4%
Low 5.9600 · High 6.5400
1W return
-10.3%
Low 5.9600 · High 6.9700
1M return
-11.2%
Low 5.9600 · High 7.2000
52W return
67.0%
Low 5.9600 · High 7.4000
Lifetime High ₹81.5800 (April 20, 2023)
Lifetime Low ₹3.6100 (Dec. 24, 2024)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
6.4
10D
6.6
20D
7.5
50D
15.8
100D
27.1
200D
43.2

Delivery and volume

Day avg. delivery
62.7%
Week avg. delivery
78.8%
Month avg. delivery
91.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

6.18
Pivot
First resistance6.39
Second resistance6.76
Third resistance6.97
First support5.81
Second support5.60
Third support5.23
Day RSI27.1
Day MFI23.5
Day MACD-2.12
Day MACD signal-2.86

Beta

1M0.56
3M0.48
1Y0.48
3Y0.08

Price change analysis

↓ -11.2%
Over 1 Month
LowHigh
5.967.20
↑ 67.0%
Over 3 Months
LowHigh
5.967.40
↑ 67.0%
Over 6 Months
LowHigh
5.967.40
↑ 67.0%
Over 1 Year
LowHigh
5.967.40
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹3 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.0100

Ranks #130 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter47.32%
  • FII/FPI5.13%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 47.40% to 47.32% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 5.13% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
5 May 2025 KHODEEAR ENTERPRISE LLP LLP Bulk Buy 1,575,000 3.4800 BSE
2 May 2025 MULTITUDE GROWTH FUNDS LIMITED Bulk Sell 2,299,500 3.5500 BSE
27 Mar 2025 FLYONTRIP SERVICES PRIVATE LIMITED Bulk Sell 1,228,500 3.1500 BSE
27 Mar 2025 FLYONTRIP SERVICES PRIVATE LIMITED . Bulk Sell 1,543,500 3.1500 BSE
27 Mar 2025 KHODEEAR ENTERPRISE LLP LLP Bulk Buy 3,087,000 3.1500 BSE
9 Dec 2024 FLYONTRIP SERVICES PRIVATE LIMITED Bulk Sell 148,500 80.0200 BSE
25 Nov 2024 FLYONTRIP SERVICES PRIVATE LIMITED Bulk Buy 11,250 74.8000 BSE
25 Nov 2024 AG DYNAMIC FUNDS LIMITED Bulk Buy 337,500 74.8000 BSE
25 Nov 2024 FLYONTRIP SERVICES PRIVATE LIMITED Bulk Sell 351,000 74.8000 BSE
17 Oct 2024 FLYONTRIP SERVICES PRIVATE LIMITED Bulk Sell 87,750 65.0000 BSE

All bulk and block deals →

Corporate Announcements

All 14 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Achyut Healthcare Ltd - 543499 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 Company Update Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management
30 Sep 2026 Company Update Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management
30 Sep 2026 Company Update Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management
29 Sep 2026 AGM/EGM Achyut Healthcare Ltd - 543499 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Company Update Achyut Healthcare Ltd - 543499 - Outcome Of AGM
25 Sep 2026 Insider Trading / SAST Achyut Healthcare Ltd - 543499 - Closure of Trading Window
5 Sep 2026 AGM/EGM Achyut Healthcare Ltd - 543499 - Notice Of 31St Annual General Meeting Of The Company For F.Y. 2025-26 To Be Held On 29Th September, 2026.
5 Sep 2026 Company Update Achyut Healthcare Ltd - 543499 - Cut-Off Date For Notice Of 31St Annual General Meeting (AGM) F.Y.2025-2026
5 Sep 2026 Company Update Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)

Weaknesses

  • Thin net profit margin (4.6%)

Opportunities

  • RSI in oversold territory (27.1) -- a technical rebound zone

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Achyut Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.